GeneLink, Inc. (GNLKQ)
OTCMKTS · Delayed Price · Currency is USD
0.00004
0.00 (0.00%)
Oct 6, 2026, 4:00 PM EST
GeneLink Market Cap
GeneLink has a market cap or net worth of $10.6 thousand as of October 20, 2026. It is the 51,779th most valuable company in the world and the 7,799th biggest in the United States. Its market cap has increased by 3,900.38% in one year.
Market Cap
10.60K
Enterprise Value
n/a
Revenue
1.58M
Global Rank
Country Rank
#7,799 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since May 17, 1999, GeneLink's market cap has decreased from 4.78M to 10.60K, a decrease of -99.78%. That is a compound annual growth rate of -21.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2025 | 26.50K | 9,900.75% |
| Dec 1, 2023 | 265.00 | - |
| Dec 22, 2022 | 265.00 | - |
| Dec 31, 2021 | 265.00 | -99.86% |
| Dec 31, 2020 | 185.51K | 40.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anebulo Pharmaceuticals | 16.31K |
| Bio-Path Holdings | 16.17K |
| Vaxxinity | 12.68K |
| ObsEva | 11.72K |
| Syros Pharmaceuticals | 10.73K |
| Bioasis Technologies | 7.94K |
| 0913693 B.C. | 7.36K |
| Statera Biopharma | 7.26K |